Molecular modeling based design of novel anticancer therapeutics that target the active sites of polymorphic GSTP1 proteins.
Publication
, Journal Article
Ali-Osman, F; Buolanwini, J
Published in: CLINICAL CANCER RESEARCH
1999
Duke Scholars
Published In
CLINICAL CANCER RESEARCH
ISSN
1078-0432
Publication Date
1999
Volume
5
Start / End Page
3841S / 3841S
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Ali-Osman, F., & Buolanwini, J. (1999). Molecular modeling based design of novel anticancer therapeutics that target the active sites of polymorphic GSTP1 proteins. CLINICAL CANCER RESEARCH, 5, 3841S-3841S.
Ali-Osman, F., and J. Buolanwini. “Molecular modeling based design of novel anticancer therapeutics that target the active sites of polymorphic GSTP1 proteins.” CLINICAL CANCER RESEARCH 5 (1999): 3841S-3841S.
Ali-Osman F, Buolanwini J. Molecular modeling based design of novel anticancer therapeutics that target the active sites of polymorphic GSTP1 proteins. CLINICAL CANCER RESEARCH. 1999;5:3841S-3841S.
Ali-Osman, F., and J. Buolanwini. “Molecular modeling based design of novel anticancer therapeutics that target the active sites of polymorphic GSTP1 proteins.” CLINICAL CANCER RESEARCH, vol. 5, 1999, pp. 3841S-3841S.
Ali-Osman F, Buolanwini J. Molecular modeling based design of novel anticancer therapeutics that target the active sites of polymorphic GSTP1 proteins. CLINICAL CANCER RESEARCH. 1999;5:3841S-3841S.
Published In
CLINICAL CANCER RESEARCH
ISSN
1078-0432
Publication Date
1999
Volume
5
Start / End Page
3841S / 3841S
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis